Editor's Choice
Webinar: Improving Ulcerative Colitis Symptoms with Probiotics
Speakers: Thomas Tompkins, R&D Manager & Ghania Sohail, Clinical Research Associate – Rosell Institute for Microbiome & Probiotics by Lallemand
Microbiome Times
Finance
BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced it has licensed a new set of bacterial targets from JSR Corporation, for the development and commercialization of phage therapies for […]
Pharma & Human Health
Just a phage? How bacteria’s predators can shape the gut microbiome
The gut microbiome is a complex, interconnected ecosystem of species. And, like any ecosystem, some organisms are predators and some are prey. A new study led by investigators at Brigham and Women’s Hospital and the […]
Editor's Choice
Pharma & Human Health
Labels of US Probiotic Products Lacking, Researchers Find
When it comes to buying probiotics, many product labels do not give consumers enough information to make an informed decision, according to a research team led by Georgetown University Medical Center. In their study, published […]
Editor's Choice
Gut check: Yale researchers describe role of bacteria in drug response
Yale researchers identified human gut microbes that metabolize over 150 therapeutic drugs, a finding that highlights the role bacteria play in determining how well individuals respond to medications, they report June 3 in the journal […]
Pharma & Human Health
Expert panel calls for increased transparency so consumers can identify quality probiotics
Probiotics are increasingly being researched and marketed as functional ingredients to enhance health. As the market for these products grows, consumers face difficulty in distinguishing between high- and low-quality products. In the current context, is […]
Pharma & Human Health
Axial Biotherapeutics Publishes Preclinical Data Highlighting Link Between Gut Microbiota & Behavioral Symptoms of ASD in Mouse Models
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the publication of new findings in Cell by Sarkis K. Mazmanian, Ph.D., the […]
Finance
Whole Biome Secures $35 Million in Series B Financing
Whole Biome, an evidence-based microbiome company, today announced that it has secured $35 million in Series B financing. The round was led by existing investor Sequoia Capital with repeat participation from True Ventures, Khosla Ventures, […]
Animal Health
Call to Action for Veterinary Industry to Support Microbiome-based Veterinary Products
Emerging scientific developments have shown that microbiome-based medicinal products do not only represent a paradigm shift in human medicine, but also in veterinary medicine. With the global initiatives to curtail the indiscriminate and irresponsible use […]
Editor's Choice
New Findings from Human Microbiome Project Reveal how Microbiome is Disrupted During IBD
A new study led by researchers from Harvard T.H. Chan School of Public Health and the Broad Institute of MIT and Harvard is the first to have observed the complex set of chemical and molecular […]